Cannabidiol induces intracellular calcium elevation and cytotoxicity in oligodendrocytes

GLIA

Volumn 58, Issue 14, 2010, Pages 1739-1747

  Mato, Susana ^a,b,c   Victoria Sánchez Gómez, María ^a,b   Matute, Carlos ^a,b,c  

^a CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED SOBRE ENFERMEDADES NEURODEGENERATIVAS CIBERNED   (Spain)

^b UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^c Neurotek   (Spain)

Author keywords

Calcium; Cannabidiol; Mitochondria; Oligodendrocyte; Reactive oxygen species

Indexed keywords

ADENOSINE A2A RECEPTOR; CALCIUM; CALPAIN; CANNABIDIOL; CARBONYL CYANIDE 4 (TRIFLUOROMETHOXY)PHENYLHYDRAZONE; CASPASE 3; CASPASE 8; CASPASE 9; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; REACTIVE OXYGEN METABOLITE; RYANODINE; TROLOX C; VANILLOID RECEPTOR;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ARTICLE; CALCIUM CELL LEVEL; CELL DEATH; CELL VIABILITY; CONCENTRATION RESPONSE; CYTOTOXICITY; DRUG EXPOSURE; EXTRACELLULAR CALCIUM; IN VITRO STUDY; MEMBRANE POTENTIAL; MENTAL HEALTH; MITOCHONDRION; NONHUMAN; OLIGODENDROGLIA; OPTIC NERVE FIBER; PRIORITY JOURNAL; RAT; SPRAGUE DAWLEY RAT;

ANIMALS; CALCIUM; CALCIUM SIGNALING; CANNABIDIOL; CELLS, CULTURED; INTRACELLULAR FLUID; NEUROTOXINS; OLIGODENDROGLIA; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY; UP-REGULATION;

EID: 78349265651     PISSN: 08941491     EISSN: 10981136     Source Type: Journal    
DOI: 10.1002/glia.21044     Document Type: Article

References (45)

1. Agurell S, Halldin M, Lindgren JE, Ohlsson A, Widman M, Gillespie H, Hollister L. 1986. Pharmacokinetics and metabolism of delta-l-tetrahydrocannabinol and other cannabinoids with emphasis on man. Pharmacol Rev 38: 21-34.
2. Alberdi E, Sánchez-Gómez MV, Cavaliere F, Pérez-Samartín A, Zugaza JL, Trullas R, Domercq M, Matute C. 2010. Amyloid beta oligomers induce Ca(2+) dysregulation and neuronal death through activation of ionotropic glutamate receptors. Cell Calcium 47: 264-272.
3. Arnone D, Barrick TR, Chengappa S, Mackay CE, Clark CA, Abou-Saleh MT. 2008. Corpus callosum damage in heavy marijuana use: Preliminary evidence from diffusion tensor tractography and tract-based spatial statistics. Neuroimage 41: 1067-1074.
4. Arseneault L, Cannon M, Witton J, Murray RM. 2004. Causal association between cannabis and psychosis: Examination of the evidence. Br J Psychiatry 184: 110-117.
5. Ashtari M, Cervellione K, Cottone J, Ardekani BA, Sevy S, Kumra S. 2009. Diffusion abnormalities in adolescents and young adults with a story of heavay cannabis use. J Psychiatr Res 43: 189-204.
6. Athanasiou A, Clarke AB, Turner AE, Kumaran NM, Vakilpour S, Smith PA, Bagiokou D, Bradshaw TD, Westwell AD, Fang L, Lobo DN, Constantinescu CS, Calabrese V, Loesch A, Alexander SP, Clothier RH, Kendall DA, Bates TE. 2007. Cannabinoid receptor agonists are mitochondrial inhibitors: A unified hypothesis of how cannabinoids modulate mitochondrial function and induce cell death. Biochem Biophys Res Commun 354: 50-55.
7. Bava S, Frank LR, McQueeny T, Schweinsburg BC, Schweinsburg AD, Tapert SF. 2009. Altered white matter microstructure in adolescent substance users. Psychiatry Res 173: 228-237.
8. Benjamins JA, Nedelkoska L, George EB. 2003. Protection of mature oligodendrocytes by inhibitors of caspases and calpains. Neurochem Res 28: 143-152.
9. Bovasso G. 2001. Cannabis abuse as risk factor for depressive symptoms. Am J Psychiatry 158: 2033-2037.
10. Butt AM. 2006. Neurotransmitter-mediated calcium signalling in oligodendrocyte physiology and pathology. Glia 54: 666-675.
11. Davis KL, Stewart DG, Friedman JI, Buchsbaum M, Harvey PD, Hof PR, Buxbaum J, Haroutunian V. 2003. White matter changes in schizophrenia: evidence for myelin-related dysfunction. Arch Gen Psychiatry 60: 443-456.
12. Domercq M, Sánchez-Gómez MV, Sherwin C, Etxebarria E, Fern R, Matute C. 2007. System xc- and glutamate transporter inhibition mediates microglial toxicity to oligodendrocytes. J Immunol 178: 6549-6556.
13. Domercq M, Perez-Samartin A, Aparicio D, Alberdi E, Pampliega O, Matute C. 2010. P2X7 receptors mediate ischemic damage to oligodendrocytes. Glia 58: 730-740.
14. Drysdale AJ, Ryan D, Pertwee RG, Platt B. 2006. Cannabidiol-induced intracellular Ca2+ elevations in hippocampal cells. Neuropharmacology 50: 621-631.
15. Fields RD. 2008. White matter in learning, cognition and psychiatric disorders. Trends Neurosci 31: 361-370.
16. Galluzzi L, Blomgren K, Kroemer G. 2009. Mitochondrial membrane permeabilization in neuronal injury. Nat Rev Neurosci 10: 481-494.
17. Giorgio A, Watkins KE, Douaud G, James AC, James S, De Stefano N, Matthews PM, Smith SM, Johansen-Berg H. 2008. Changes in white matter microstructure during adolescence. Neuroimage 39: 52-61.
18. Hampson AJ, Grimaldi M, Axelrod J, Wink D. 1998. Cannabidiol and (-)Delta9-tetrahydrocannabinol are neuroprotective antioxidants. Proc Natl Acad Sci USA 95: 8268-8273.
19. Henquet C, Krabbendam L, Spauwen J, Kaplan C, Lieb R, Wittchen HU, van Os J. 2005. Prospective cohort study of cannabis use, predisposition for psychosis, and psychotic symptoms in young people. BMJ 330: 11-14.
20. Hong SJ, Dawson TM, Dawson VL. 2004. Nuclear and mitochondrial conversations in cell death: PARP-1 and AIF signaling. Trends Pharmacol Sci 25: 259-264.
21. Iijima T. 2006. Mitochondrial membrane potential and ischemic neuronal injury. Neurosci Res 55: 234-243.
22. Izzo AA, Borrelli F, Capasso R, Di Marzo V, Mechoulam R. 2009. Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb. Trends Pharmacol Sci 30: 515-527.
23. Jurewicz A, Matysiak M, Tybor K, Kilianek L, Raine CS, Selmaj K. 2005. Tumour necrosis factor-induced death of adult human oligodendrocytes is mediated by apoptosis inducing factor. Brain 128: 2675-2688.
24. Kaufmann SH, Hengartner MO. 2001. Programmed cell death: alive and well in the new millenium. Trends Cell Biol 11: 526-534.
25. Kim JM, Bae HR, Park BS, Lee JM, Ahn HB, Rho JH, Yoo KW, Park WC, Rho SH, Yoon HS, Yoo YH. 2003. Early mitochondrial hyperpolarization and intracellular alkalinization in lactacystin-induced apoptosis of retinal pigment epithelial cells. J Pharmacol Exp Ther 305: 474-481.
26. Li PF, Dietz R, von Harsdorf R. 1999. p53 regulates mitochondrial membrane potential through reactive oxygen species and induces cytochrome c-independent apoptosis blocked by Bcl-2. EMBO J 18: 6027-6036.
27. Ligresti A, Moriello AS, Starowicz K, Matias I, Pisanti S, De Petrocellis L, Laezza C, Portella G, Bifulco M, Di Marzo V. 2006. Antitumor activity of plant cannabinoids with emphasis on the effect of cannabidiol on human breast carcinoma. J Pharmacol Exp Ther 318: 1375-1387.
28. Liu HN, Giasson BI, Mushynski WE, Almazan G. 2002. Liu AMPA receptor-mediated toxicity in oligodendrocyte progenitors involves free radical generation and activation of JNK, calpain and caspase 3. J Neurochem 82: 398-409.
29. Massi P, Vaccani A, Ceruti S, Colombo A, Abbracchio MP, Parolaro D. 2004. Antitumor effects of cannabidiol, a nonpsychoactive cannabinoid, on human glioma cell lines. J Pharmacol Exp Ther 308: 838-345.
30. Mato S, Alberdi E, Ledent C, Watanabe M, Matute C. 2009. CB1 cannabinoid receptor-dependent and -independent inhibition of depolarization-induced calcium influx in oligodendrocytes. Glia 57: 295-306.
31. Matute C. 2010. Calcium dyshomeostasis in white matter pathology. Cell Calcium 47: 150-157.
32. Matochik JA, Eldreth DA, Cadet JL, Bolla KI. 2005. Altered brain tissue composition in heavy marijuana users. Drug Alcohol Depend 77: 23-30.
33. McKallip RJ, Jia W, Schlomer J, Warren JW, Nagarkatti PS, Nagarkatti M. 2006. Cannabidiol-induced apoptosis in human leukemia cells: A novel role of cannabidiol in the regulation of p22phox and Nox4 expression. Mol Pharmacol 70: 897-908.
34. Medina KL, Nagel BJ, Park A, McQueeny T, Tapert SF. 2007. Depressive symptoms in adolescents: Associations with white matter volume and marijana use. J Child Psychol Psychiatry 48: 592-600.
35. 2+- and redox-dependent production of nitric oxide. J Immunol 17: 5188-5197.
36. Paez PM, Fulton DJ, Spreuer V, Handley V, Campagnoni CW, Campagnoni AT. 2009. Regulation of store-operated and voltage-operated Ca2+ channels in the proliferation and death of oligodendrocyte precursor cells by golli proteins. ASN Neuro 1: pii.
37. Poppe M, Reimertz C, Düssmann H, Krohn AJ, Luetjens CM, Böckelmann D, Nieminen AL, Kögel D, Prehn JH. 2001. Dissipation of potassium and proton gradients inhibits mitochondrial hyperpolarization and cytochrome c release during neural apoptosis. J Neurosci 21: 4551-4563.
38. Pryce G, Baker D. 2005. Emerging properties of cannabinoid medicines in management of multiple sclerosis. Trends Neurosci 28: 272-276.
39. 3 receptors contributes to neuronal excitotoxicity. Cell Calcium 46: 273-281.
40. Ryan D, Drysdale AJ, Lafourcade C, Pertwee RG, Platt B. 2009. Cannabidiol targets mitochondria to regulate intracellular Ca2+ levels. J Neurosci 29: 2053-2063.
41. SAMSHA (Substance Abuse and Mental Health Service Administration). 2007. Results from the 2007 National Survey on Drug Use and Health. NSDUH Series H-25. DHHS Rockville, MD: National Findings Office of Applied Studies.
42. Sánchez-Gómez MV, Alberdi E, Ibarretxe G, Torre I, Matute C. 2003. Caspase-dependent and caspase-independent oligodendrocyte death mediated by AMPA and kainate receptors. J Neurosci 23: 9519-9528.
43. Skulachev VP. 2006. Bioenergetic aspects of apoptosis, necrosis and mitoptosis. Apoptosis 11: 473-485.
44. von Haefen C, Wieder T, Essmann F, Schulze-Osthoff K, Dörken B, Daniel PT. 2003. Paclitaxel-induced apoptosis in BJAB cells proceeds via a death receptor-independent, caspases-3/-8-driven mitochondrial amplification loop. Oncogene 22: 2236-2247.
45. Wieder T, Essmann F, Prokop A, Schmelz K, Schulze-Osthoff K, Beyaert R, Dörken B, Daniel PT. 2001. Activation of caspase-8 in drug-induced apoptosis of B-lymphoid cells is independent of CD95/Fas receptor-ligand interaction and occurs downstream of caspase-3. Blood 97: 1378-1387.